SM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development.
<h4>Background</h4>Artemisinin and its derivatives were reported to possess strong regulatory effects on inflammation and autoimmune diseases. This study was designed to examine the therapeutic effects and underlying mechanisms of SM934, a water-soluble artemisinin analogue, on lupus-pro...
Enregistré dans:
Auteurs principaux: | Li-Fei Hou, Shi-Jun He, Xin Li, Chun-Ping Wan, Yang Yang, Xiao-Hui Zhang, Pei-Lan He, Yu Zhou, Feng-Hua Zhu, Yi-Fu Yang, Ying Li, Wei Tang, Jian-Ping Zuo |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c5456729a7064a86821d9c88ed18c41e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Fecal microbiota changes in NZB/W F1 mice after induction of lupus disease
par: Yen-Fu Chen, et autres
Publié: (2021) -
Acta Nº934
par: Banco Central de Chile
Publié: (2019) -
Elevated Serum Interleukin-34 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity
par: Huan Huan Xie, et autres
Publié: (2018) -
Death receptor 6 contributes to autoimmunity in lupus-prone mice
par: Daisuke Fujikura, et autres
Publié: (2017) -
CD38 Correlates with an Immunosuppressive Treg Phenotype in Lupus-Prone Mice
par: Jocelyn C. Pérez-Lara, et autres
Publié: (2021)